Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease.

A 24-kDa recombinant protein from Trypanosoma cruzi (rTc24) was evaluated by enzyme-linked immunosorbent assay (ELISA) and Western blot (immunoblot) tests to identify treated chagasic patients considered parasitologically cured on the basis of persistently negative tests of hemocultures and lytic an...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	J Clin Microbiol
Egile Nagusiak:	Krautz, G M, Galvão, L M, Cançado, J R, Guevara-Espinoza, A, Ouaissi, A, Krettli, A U
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Microbiology (ASM) 1995
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC228340/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7559953/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.33.8.2086-2090.1995
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!